Guangzhou Wondfo Biotech Co Ltd (300482) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.99 Million ≈ $17.12 Million USD) by net assets (CN¥5.56 Billion ≈ $813.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Guangzhou Wondfo Biotech Co Ltd to measure how many days the company can operate on defensive assets alone.

Guangzhou Wondfo Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Wondfo Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Wondfo Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Labrador Iron Ore Royalty Corp TO:LIF	0.051x
Alimak Hek Group AB ST:ALIG	0.115x
Zhejiang Huangma Technology Co Ltd SHG:603181	0.043x
Paymentus Holdings, Inc. NYSE:PAY	0.052x
Teladoc Inc NYSE:TDOC	0.071x
Beijing Jingwei Hirain Technologies Co. Ltd. A SHG:688326	-0.001x
Prudent Corporate Advisory Services Limited NSE:PRUDENT	0.133x
Distribution Solutions Group Inc NASDAQ:DSGR	0.059x

Annual Cash Flow Conversion Efficiency for Guangzhou Wondfo Biotech Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Guangzhou Wondfo Biotech Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.47 Billion ≈ $800.95 Million	CN¥463.04 Million ≈ $67.76 Million	0.085x	+32.15%
2024-12-31	CN¥5.65 Billion ≈ $826.81 Million	CN¥361.71 Million ≈ $52.93 Million	0.064x	-23.90%
2023-12-31	CN¥4.61 Billion ≈ $675.26 Million	CN¥388.19 Million ≈ $56.80 Million	0.084x	-77.31%
2022-12-31	CN¥4.54 Billion ≈ $663.99 Million	CN¥1.68 Billion ≈ $246.15 Million	0.371x	+95.36%
2021-12-31	CN¥3.50 Billion ≈ $512.76 Million	CN¥664.93 Million ≈ $97.30 Million	0.190x	-46.50%
2020-12-31	CN¥2.99 Billion ≈ $438.06 Million	CN¥1.06 Billion ≈ $155.38 Million	0.355x	+181.66%
2019-12-31	CN¥2.46 Billion ≈ $360.06 Million	CN¥309.86 Million ≈ $45.34 Million	0.126x	+9.42%
2018-12-31	CN¥2.15 Billion ≈ $314.82 Million	CN¥247.61 Million ≈ $36.23 Million	0.115x	-18.89%
2017-12-31	CN¥1.19 Billion ≈ $174.13 Million	CN¥168.85 Million ≈ $24.71 Million	0.142x	+8.28%
2016-12-31	CN¥854.75 Million ≈ $125.08 Million	CN¥112.01 Million ≈ $16.39 Million	0.131x	-30.35%
2015-12-31	CN¥700.64 Million ≈ $102.53 Million	CN¥131.81 Million ≈ $19.29 Million	0.188x	-43.56%
2014-12-31	CN¥313.43 Million ≈ $45.86 Million	CN¥104.47 Million ≈ $15.29 Million	0.333x	-20.24%
2013-12-31	CN¥241.47 Million ≈ $35.33 Million	CN¥100.91 Million ≈ $14.77 Million	0.418x	+1.91%
2012-12-31	CN¥182.48 Million ≈ $26.70 Million	CN¥74.84 Million ≈ $10.95 Million	0.410x	+148.81%
2011-12-31	CN¥144.61 Million ≈ $21.16 Million	CN¥23.83 Million ≈ $3.49 Million	0.165x	--

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.33 Billion

CN¥9.06 Billion CNY

Market Cap Rank

#7875 Global

#1872 in China

Share Price

CN¥19.35

Change (1 day)

-4.30%

52-Week Range

CN¥16.07 - CN¥25.56

All Time High

CN¥92.01